{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T12:20:21Z","timestamp":1792412421891,"version":"4.4.0"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T00:00:00Z","timestamp":1657670400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:p>Cervical SCNEC is a rare and highly malignant invasive tumor. The incidence is low, at less than 5% of all cervical cancers. Moreover, most patients with small cell carcinoma are interrelated with high risk HPV (more familiar HPV 18). Compared to squamous cell carcinoma or adenocarcinoma, patients of cevical SCNEC are more prone to lymph node invasion early, so the clinical manifestation is usually local or distant metastasis. We summarized the clinical features of 19 patients with cervical small cell carcinoma in the Second Affiliated Hospital of Dalian Medical University from 2012 to 2021, and retrospectively analyzed data from 1576 patients in 20 related studies and more than 50 pieces of literature in recent years by searching PubMed, Google schalor, Cochrane Library, Clinicalkey, and other databases. The collected patient data included age, clinical manifestation, TCT, HPV detection, the size and morphology of the tumor, local invasion depth, stage, lymph node status, initial treatment method, tumor-free survival, and so on. The positive rates of CGA, SYN, and CD56 in our cases were high, and NSE was a moderately sensitive index. P16 and Ki67 were the most sensitive, and all patients were positive. We found that multimodal treatment can indeed improve tumor-free survival (DFS), but the prognosis of patients is still very poor. For the early stages, our treatment principles refer to the guidelines of SGO, international gynecological cancer Cooperation (GCIG), and NCCN. We suggest a combination of surgery, radiotherapy, and chemotherapy. However, the general state of advanced patients is poor, whether they can tolerate the operation after neoadjuvant chemotherapy, whether the operation area can remain tumor-free, and whether this treatment will prolong the survival time of patients still need to be further discussed. In order to better prolong the tumor-free survival and prognosis of patients, we need to find gene changes suitable for targeted therapy, so as to complete the clinical application of these treatment methods. Further works are needed to explore more effective therapy for cervical SCNEC.<\/jats:p>","DOI":"10.3389\/fcimb.2022.916506","type":"journal-article","created":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T04:43:55Z","timestamp":1657687435000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":42,"title":["Small Cell (Neuroendocrine) Carcinoma of the Cervix: An Analysis for 19 Cases and Literature Review"],"prefix":"10.3389","volume":"12","author":[{"given":"JunLing","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,7,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1002\/1097-0142(19940201)73:3<672::AID-CNCR2820730328>3.0.CO;2-R","article-title":"Small Cell Carcinoma of the Cervix. A Clinicopathologic Study of 26 Patients","volume":"73","author":"Abeler","year":"1994","journal-title":"Cancer"},{"key":"B2","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1177\/1758834009356014","article-title":"Targeted therapies in Small Cell Lung Cancer: A Review","volume":"2","author":"Abidin","year":"2010","journal-title":"Ther. Adv. Med. Oncol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.pvr.2018.03.005","article-title":"Contribution of Human Papillomavirus in Neuroendocrine Tumors From a Series of 10, 575 Invasive Cervical Cancer Cases","volume":"5","author":"Alejo","year":"2018","journal-title":"Papillomavirus Res."},{"key":"B4","doi-asserted-by":"publisher","first-page":"30482","DOI":"10.1016\/S2214-109X(19)30482-6","article-title":"Estimates of Incidence and Mortality of Cervical Cancer in 2018: A World- Wide Analysis","volume":"8","author":"Arbyn","year":"2020","journal-title":"Lancet Global Health"},{"key":"B5","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.ygyno.2014.05.017","article-title":"Small Cell Carcinoma of the Gynecologic Tract: A Multifaceted Spectrum of Lesions","volume":"134","author":"Atienza-Amores","year":"2014","journal-title":"Gynecol Oncol."},{"key":"B6","volume-title":"NCCN Clinical Practice Guidelines in Oncology, Cervical Cancer, Version\u00a01","author":"Abu-rustum","year":"2022"},{"key":"B7","doi-asserted-by":"publisher","first-page":"17077","DOI":"10.1038\/nrdp.2017.77","article-title":"Merkel Cell Carcinoma","volume":"3","author":"Becker","year":"2017","journal-title":"Nat. Rev. Dis. primers."},{"key":"B8","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1006\/gyno.2001.6201","article-title":"Neuroendocrine Cervical Carcinoma: A Diagnostic and Therapeutic Challenge","volume":"82","author":"Bermudez","year":"2001","journal-title":"Gynecol Oncol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"4431","DOI":"10.21873\/anticanres.15250","article-title":"Radical Surgery After Neoadjuvant Chemotherapy for Locally Advanced Neuroendocrine Cancer of the Cervix","author":"Caruso","year":"2021","journal-title":"Anticancer Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1097\/AOG.0b013e318173570b","article-title":"Incidence, Mortality, and Prognostic Factors of Small Cell Carcinoma of the Cervix","volume":"111","author":"Chen","year":"2008","journal-title":"Obstet Gynecol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1111\/his.13723","article-title":"PD-L1 and IDO Expression in Cervical and Vulvar Invasive and Intraepithelial Squamous Neoplasias: Implications for Combination Immunotherapy","volume":"74","author":"Chinn","year":"2019","journal-title":"Histopathol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.jaad.2017.12.001","article-title":"Merkel Cell Carcinoma: An Update and Review: Pathogenesis, Diagnosis, and Staging","volume":"78","author":"Coggshall","year":"2018","journal-title":"J. Am. Acad. Dermatol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.ajog.2010.04.019","article-title":"Small Cell Carcinoma of the Cervix: Treatment and Survival Outcomes of 188 Patients","volume":"203","author":"Cohen","year":"2010","journal-title":"Am. J. Obstetrics Gynecol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1053\/adpa.2002.36661","article-title":"Small Cell Carcinoma of the Cervix: A Clinicopathologic and Immunohistochemical Study of 23 Cases","volume":"6","author":"Conner","year":"2002","journal-title":"Ann. Diagn. Pathol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3892\/mco.2013.193","article-title":"A Retrospective Clinicopathological Analysis of Small-Cell Carcinoma of the Uterine Cervix","volume":"2","author":"Dongol","year":"2014","journal-title":"Mol. Clin. Oncol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s12885-015-1188-y","article-title":"A Population-Based Study of Incidence and Patient Survival of Small Cell Carcinoma in the United States, 1992-2010","volume":"15","author":"Dores","year":"2015","journal-title":"BMC Cancer."},{"key":"B17","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1200\/PO.19.00248","article-title":"Unique Genomic Landscape of High-Grade Neuroendocrine Cervical Carcinoma:Implications for Rethinking Current Treatment Paradigms","volume":"4","author":"Eskander","year":"2020","journal-title":"JCO Precis. Oncol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.ygyno.2016.12.003","article-title":"Neuroendrocrine Tumors of the Uterine Cervix: A Therapeutic Challenge for Gynecologic Oncologists","volume":"144","author":"Gadducci","year":"2017","journal-title":"Gynecol Oncol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.ygyno.2011.04.011","article-title":"Neuroendocrine Tumors of the Gynecologic Tract:a Society of Gynecologic Oncology (SGO) Clinical Document","author":"Gardner","year":"2011","journal-title":"Gynecol Oncol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.3390\/cancers12051211","article-title":"Neuroendocrine Carcinoma of the Uterine Cervix:a Clinicopathologic and Immunohistochemical Study With Focus on Novel Markers (Sst2-Sst5)","author":"Inzani","year":"2020","journal-title":"Cancers"},{"key":"B21","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1097\/01.pgp.0000139637.01977.61","article-title":"Small Cell Neuroendocrine Carcinomas of the Uterine Cervix: A Histological, Immunohistochemical, and Molecular Genetic Study","volume":"23","author":"Ishida","year":"2004","journal-title":"Int. J. Gynecolog Pathol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ygyno.2017.10.027","article-title":"Prognostic Factors and Optimal Therapy for Stages I-II Neuroendocrine Carcinomas of the Uterine Cervix:a Multi-Center Retrospective Study","author":"Ishikawa","year":"2018","journal-title":"Gynecol Oncol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"4743","DOI":"10.1002\/cam4.4034","article-title":"PD-L1, PARP1, and MMRs as Potential Therapeutic Biomarkers for Neuroendocrine Cervical Cancer","volume":"10","author":"Ji","year":"2021","journal-title":"Cancer Med."},{"key":"B24","first-page":"307","volume-title":"WHO Classification of Tumours of the Female Reproductive Organs","author":"Kurman","year":"2014"},{"key":"B25","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13000-018-0709-9","article-title":"Cervical Small Cell Carcinoma Frequently Presented in Multiple High Risk HPV Infection and Often Associated With Other Type of Epithelial Tumors","volume":"13","author":"Li","year":"2018","journal-title":"Diagn. Pathol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ygyno.2014.01.042","article-title":"A Systematic Review Comparing Cisplatin and Carboplatin Plus Paclitaxel-Based Chemotherapy for Recurrent or Metastatic Cervical Cancer","volume":"133","author":"Lorusso","year":"2014","journal-title":"Gynecol Oncol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/B978-0-323-35909-2.00008-4","article-title":"Neoplastic Lesions of the Cervix","volume":"4","author":"Park","year":"","journal-title":"Surgical Pathology Clinics"},{"key":"B28","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.ygyno.2021.04.019","article-title":"The Next Generation Sequencing of Cancer-Related Genes in Small Cell Neuroendocrine Carcinoma of the Cervix[J]","volume":"161","author":"Pei","year":"2021","journal-title":"Gynecol Oncol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13000-017-0631-6","article-title":"Programmed Death-Ligand 1 (PD-L1) is Expressed in a Significant Number of the Uterine Cervical Carcinomas","volume":"12","author":"Reddy","year":"2017","journal-title":"Diagn. pathol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/nrclinonc.2017.71","article-title":"Unravelling the Biology of SCLC: Implications for Therapy","volume":"14","author":"Sabari","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.ajog.2011.03.008","article-title":"Posttreatment Surveillance and Diagnosis of Recurrence in Women With Gynecologic Malignancies:Society of Gynecologic Oncologists Recommendations","author":"Salani","year":"2011","journal-title":"Am. J. Obstet Gynecol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1136\/ijgc-2019-000504","article-title":"Updates and Management Algorithm for Neuroendocrine Tumors of the Uterine Cervix","volume":"29","author":"Salvo","year":"2019","journal-title":"Int. J. Gynecol Cancer"},{"key":"B33","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3322\/caac.21208","article-title":"Cancer Statistics, 2014","volume":"64","author":"Siegel","year":"2014","journal-title":"CA Cancer J. Clin."},{"key":"B34","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1002\/cncr.30667","article-title":"Cervical Cancer: A Global Health Crisis","volume":"123","author":"Small","year":"2017","journal-title":"Cancer."},{"key":"B35","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.ygyno.2016.09.011","article-title":"Patterns of Recurrence and Survival in Neuroendocrine Cervical Cancer","author":"Stecklein","year":"2016","journal-title":"Gynecol Oncol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1097\/00000478-199101000-00003","article-title":"Small-Cell Neuroendocrine Carcinoma of the Cervix. A Human Papillomavirus Type 18- Associated Cancer","volume":"15","author":"Stoler","year":"1991","journal-title":"Am. J. Surg. Pathol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1016\/j.ejca.2011.12.014","article-title":"Primary Treatment and Prognostic Factors of Small Cell Neuroendocrine Carcinoma of the Uterine Cervix:a Taiwanese Gynecologic Oncology Group Study","author":"Wang","year":"2012","journal-title":"Eur. J. Cancer"},{"key":"B38","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.adro.2019.08.008","article-title":"Patterns of Care and Outcomes for Small Cell Carcinoma of the Cervix: A National Retrospective Analysis of 542 Cases","volume":"5","author":"Wharton","year":"2020","journal-title":"Adv. Radiat. Oncol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1097\/PAS.0000000000001042","article-title":"Next-Generation Sequencing Reveals Recurrent Somatic Mutations in Small Cell Neuroendocrine Carcinoma of the Uterine Cervix","volume":"42","author":"Xing","year":"2018","journal-title":"Am. J. Surg. Pathol."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2022.916506\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T04:44:00Z","timestamp":1657687440000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2022.916506\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,13]]},"references-count":39,"alternative-id":["10.3389\/fcimb.2022.916506"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2022.916506","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,13]]},"article-number":"916506"}}